Centre for Cancer and Stem Cell Research

Advances in the prevention and treatment of cancer are the result of hard work, patience, ingenuity, careful planning, and significant investments of time and resources. Capitalising on these investments requires looking back at how far we have come and looking forward to identifying the areas in which we can do our best work. Cancer research in IMU has made, and continues to make, critical advances in the understanding of cancer. As part of the IMU Institute for Research, Development and Innovation (IRDI), the Centre for Cancer and Stem Cell (CCR) will conduct basic, translational, and clinical research — from fundamental research on the origins of cancer, to clinical trials that test promising discoveries, to development of novel therapies and prevention approaches to cancer. Our goal is to work in tandem with our academic and industry colleagues to share discoveries made here as broadly as possible.
By maintaining a clear focus on our purpose, we will build synergy around a seamless, integrated, and continuous discovery, development, and delivery process. Our research will be targeted to those areas of pursuit that show greatest promise. New development will promote the most compelling interventions based on evidence emerging from that discovery. The delivery of evidence-based interventions will be universal. What we learn in public health and medical practice will foster our understanding of the biology of cancer and make possible increasingly more effective interventions.

Purpose

The purpose of the Centre for Cancer and Stem Cell Research is multifaceted, aimed at advancing the understanding, diagnosis, treatment, and prevention of cancer and diseases related to stem cells. The key objectives include:

01

Research and Innovation

Conduct cutting-edge research to uncover the molecular and cellular mechanisms of cancer and stem cell biology. This includes understanding how cancers develop, progress, and respond to treatments, as well as how stem cells can be used in regenerative medicine and therapy.

02

Translational Medicine

Bridge the gap between laboratory research and clinical applications. Develop new therapies, drugs, and treatment protocols based on research findings, and work to bring these innovations to patients through clinical trials.

03

Education and Training

Provide education and training for the next generation of scientists, physicians, and healthcare professionals. This includes offering graduate and postdoctoral programmes, workshops, seminars, and continuing medical education opportunities.

04

Patient Care and Support

Improve patient outcomes by integrating research with clinical practice. Develop personalized medicine approaches tailored to individual patients’ genetic and molecular profiles. Offer support services for patients and their families, including counseling, rehabilitation, and palliative care.

05

Collaboration and Partnerships

Foster collaboration between researchers, clinicians, academic institutions, and industry partners. Participate in national and international research networks and consortia to share knowledge, resources, and technology.

06

Public Outreach and Advocacy

Raise public awareness about cancer and stem cell research. Engage with the community through public lectures, educational materials, and outreach programmes. Advocate for policies that support research funding, patient rights, and access to advanced treatments.

07

Ethical and Regulatory Compliance

Ensure that all research and clinical practices adhere to ethical guidelines and regulatory standards. Address ethical issues related to stem cell research, such as the use of embryonic stem cells and gene editing technologies.

By fulfilling these objectives, the Center of Cancer and Stem Cell Research aims to contribute significantly to the fight against cancer and the advancement of regenerative medicine, ultimately improving health outcomes and quality of life for patients worldwide.

Focus Area

The Centre for Cancer and Stem Cell Research envisions transforming cancer into a manageable and survivable disease through cutting-edge research, development, and innovation.

01

Cell & Stem Cell Biology

This scope focuses on understanding the fundamental biology of cells and stem cells, including how they develop, differentiate, and respond to various signals. The research supports both cancer and regenerative medicine by uncovering the molecular and epigenetic mechanisms driving health and disease.

Research Areas:

  • Cell Genomics – Investigating the genetic makeup and mutations of cells to understand disease mechanisms.
  • Bioinformatics – Applying computational tools to analyze complex biological data and uncover new insights.
  • Cell Proteomics – Studying the full set of proteins expressed in cells to identify potential biomarkers or therapeutic targets.
  • Epigenetic Induction/Modulation – Exploring how gene expression is regulated without altering DNA sequences to control cell behavior.
  • Cell Regeneration Mechanisms – Understanding how cells regenerate and repair tissues for potential therapeutic applications.

02

Cell-based Innovation

This scope aims to develop novel products and technologies using cell-based systems for healthcare and therapeutic applications. It bridges research and translational efforts to bring cell-derived innovations closer to clinical and industry use.

Research Areas:

  • Pre-clinical Model Development – Creating in vitro and in vivo models to test safety and efficacy of new therapies.
  • Stem Cell Products – Developing applications and formulations involving stem cells for regenerative therapies.
  • Biological Products – Innovating products derived from biological sources for medical or research use.
  • Bioengineering Products – Integrating biology with engineering to design functional systems like organoids or biocompatible scaffolds.
  • Cell-based Health Technology – Advancing tools and platforms that leverage cell technology for diagnosis, monitoring, or treatment.
  • Cell-based Therapy – Developing therapeutic strategies that utilize living cells to treat diseases, especially cancers and degenerative conditions.

03

Cancer Diagnosis

This scope focuses on improving the early detection, stratification, and monitoring of cancer through various diagnostic approaches. It integrates molecular, pathological, and epidemiological tools to enhance precision and timeliness of cancer diagnosis.

Research Areas:

  • Cancer Genomics – Decoding the genetic mutations and variations associated with different cancers.
  • Cancer Biomarkers – Identifying molecular indicators for early detection, prognosis, or therapeutic response.
  • Cancer Microbiome – Studying the role of microbial communities in cancer initiation and progression.
  • Cancer Pathology – Exploring the cellular and tissue changes associated with cancer.
  • Cancer Epidemiology – Analyzing patterns, causes, and effects of cancer in populations.
  • Cancer Risk – Investigating genetic, environmental, and lifestyle factors contributing to cancer development.
  • Cancer Modeling – Building biological or computational models to simulate cancer behavior.
  • Cancer Monitoring – Developing tools and approaches to track disease progression and treatment response.

04

Cancer Treatment

This scope is dedicated to advancing therapeutic strategies for cancer through surgical, radiological, and pharmacological interventions. It supports the development and delivery of more precise and effective treatments.

Research Areas:

  • Cancer Surgery – Enhancing surgical techniques and outcomes for cancer removal.
  • Radiation & Radiopharmaceuticals – Improving the use of radiation and radioactive compounds in cancer therapy.
  • Cancer Drug Discovery & Design – Identifying and designing new compounds with anticancer activity.
  • Cancer Drug Delivery – Developing innovative methods to deliver drugs selectively to tumor sites with minimal side effects.

05

Cancer Care

This scope addresses the holistic management of cancer patients, encompassing physical, psychological, and social dimensions. It emphasizes multidisciplinary support, equitable access, and quality of life improvement across the cancer care continuum.

Research Areas:

  • Medical Care – Optimizing clinical management and treatment regimens.
  • Pharmaceutical Care – Enhancing medication safety, efficacy, and patient adherence.
  • Dental Care – Managing oral health issues related to cancer and its treatments.
  • Psychological Care – Supporting mental health and emotional resilience of cancer patients.
  • Nutritional Care – Addressing dietary needs to support recovery and treatment.
  • Nursing Care – Strengthening the role of nurses in providing comprehensive patient support.
  • T&CM Care (Traditional & Complementary Medicine) – Exploring integrative approaches to cancer care.
  • Data Stewardship – Managing and safeguarding patient data to support evidence-based decisions.
  • Healthcare Economics – Evaluating the cost-effectiveness and sustainability of cancer care strategies.
  • Healthcare Advocacy – Promoting patient rights, awareness, and community engagement.
  • Healthcare Policy – Informing and shaping policies that enhance cancer prevention, care, and control.

Core Facilities

The Center of Cancer and Stem Cell Research has a range of core facilities to support its multidisciplinary research. These core facilities provide essential services, equipment, and expertise to facilitate cutting-edge research and clinical translation. Key core facilities include:
null

Bioinformatics Core

Offers computational resources and expertise in genomic and transcriptomic data analysis. The Bioinformatics Core supports a wide range of applications, from identifying genetic mutations associated with diseases to studying gene regulatory networks and conducting comparative genomics. It serves as a vital hub for researchers needing robust computational support to enhance their understanding of biological processes and accelerate discoveries in genetics and molecular biology.
null

Proteomics Core

Equipped with Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and other proteomics technologies including polyacrylamide agar gel electrophoresis (PAGE). ICP-MS provides a sensitive elemental analysis to trace elements and metalloproteins involved in cancer progression and stem cell differentiation. PAGE facilitates the separation of proteins based on size and charge, aiding in the identification of protein markers and studying protein interactions critical for cancer biology and regenerative medicine.
null

Flow Cytometry and Cell Sorting Core

Provides flow cytometry and cell sorting services for analyzing and isolating specific cell populations based on their surface markers and other properties. Essential for studying cancer and stem cell biology.
null

Imaging Core

Equipped with advanced imaging technologies such as multiphoton microscopy, live-cell imaging, and high-content screening. Provides support for visualizing cellular and molecular processes.
null

Animal Facility and Preclinical Models Core

Provides housing and care for laboratory animals, as well as expertise in developing and using animal models for cancer and stem cell research. Includes facilities for generating genetically modified animals and performing in vivo studies.
null

Cell Culture Core

Provides facilities and expertise for culturing and maintaining cancer cells, stem cells, and other cell types. Includes specialized equipment for sterile work, cell incubation, and monitoring.
null

Histology and Pathology Core

Offers services for tissue processing, embedding, sectioning, and staining. Provides expertise in histological and pathological analysis of tissue samples, including immunohistochemistry.
null

Clinical Trials Core

Supports the design, implementation, and management of clinical trials. Provides services such as protocol development, regulatory compliance, patient recruitment, data management, and statistical analysis.
null

Biobanking Core

Collects, stores, and manages biological specimens such as blood, tissue, and cell samples. Provides annotated biospecimens for research and supports biobanking best practices and ethical guidelines.
null

Stem Cell Core

Provides expertise and resources for working with various types of stem cells, including embryonic stem cells, induced pluripotent stem cells (iPSCs), and adult stem cells. Offers services such as cell reprogramming, differentiation, and characterization.
null

Biostatistics and Epidemiology Core

Provides statistical analysis and study design support for research projects. Offers expertise in biostatistics, epidemiology, and data interpretation.
null

Ethics and Regulatory Affairs Core

Ensures compliance with ethical guidelines and regulatory standards. Provides support for Institutional Review Board (IRB) submissions, informed consent processes, and research ethics training.

Strategic Plan

Strategic Goals and Objectives

  • Enhance Research Excellence
  • Expand Translational Research and Clinical Trials
  • Advance Stem Cell Research and Therapy
  • Promote Education and Training
  • Foster Collaboration and Partnerships
  • Ensure Sustainable Growth and Funding
  • Uphold Ethical Standards and Regulatory Compliance

Services Offered

The Centre for Cancer and Stem Cell Research offers a comprehensive range of services to support its multifaceted mission. These services will cater to researchers, clinicians, patients, and the broader community. The list of services include:
null

Bioinformatics and Data Analysis

  • Computational data analysis
  • Bioinformatics tools and software support
  • Data integration and interpretation

null

Proteomics Services

  • Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
  • Polyacrylamide agar gel electrophoresis (PAGE)

null

Flow Cytometry and Cell Sorting

  • Cell population analysis
  • Cell sorting based on surface markers
  • Multiparametric flow cytometry

null

Advanced Imaging

  • Confocal and multiphoton microscopy
  • Live-cell imaging
  • High-content screening

null

Animal Models and Preclinical Studies

  • Housing and care for laboratory animals
  • Development of genetically modified animals
  • In vivo efficacy and safety studies

null

Cell Culture and Stem Cell Services

  • Culture and maintenance of cancer and stem cells
  • Stem cell reprogramming and differentiation
  • Characterization of stem cell properties

null

Histology and Pathology

  • Tissue processing, embedding, and sectioning
  • Histological staining and analysis
  • Immunohistochemistry and in situ hybridization

null

Clinical Trials Support

  • Protocol development and regulatory compliance
  • Patient recruitment and enrollment
  • Data management and statistical analysis

null

Drug Discovery and Development

  • High-throughput screening
  • Medicinal chemistry support
  • Preclinical drug testing

null

Training Programmes

  • Graduate and postdoctoral programmes
  • Fellowships and scholarships
  • Workshops and seminars

null

Public Education and Outreach

  • Public lectures and educational materials
  • Community engagement and awareness programmes
  • Patient and family education sessions

null

Grant Writing and Funding Support

  • Assistance with grant applications
  • Identification of funding opportunities
  • Budget planning and resource allocation

null

Collaboration and Partnership Development

  • Establishing and managing research partnerships
  • Facilitating interdisciplinary collaboration
  • Networking with academic, industry, and government partners

null

Ethics and Regulatory Compliance

  • Ethics training and education
  • Support for Institutional Review Board (IRB) submissions
  • Ensuring compliance with regulatory guidelines

null

Biobanking

  • Collection, storage, and management of biological specimens
  • Providing annotated biospecimens for research
  • Ensuring biobanking best practices and ethical guidelines

null

Statistical and Epidemiological Support

  • Statistical analysis and study design
  • Data interpretation and reporting
  • Epidemiological research and analysis

null

Facility and Equipment Access

  • Access to state-of-the-art laboratories and equipment
  • Technical support and training for equipment use
  • Shared research spaces and resources

Expertise / Team

Centre Head

Prof Ts Dr Mai Chun Wai

Senior Research Fellow & Professor, Institute for Research, Development and Innovation

Bioinformatics Core Facility

Dr Nurul Hanis Binti Ramzi

Research Fellow & Senior Lecturer, Institute for Research, Development and Innovation